ArticleHaematologica2019

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.

Maria Rosaria Sapienza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.